Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 2
2016 1
2017 7
2018 7
2019 6
2020 8
2021 6
2022 14
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Correction to: Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease.
Nagayama I, Kamimura K, Owaki T, Ko M, Nagoya T, Tanaka Y, Ohkoshi M, Setsu T, Sakamaki A, Yokoo T, Kamimura H, Terai S. Nagayama I, et al. Among authors: sakamaki a. Hepatol Int. 2024 Mar 7. doi: 10.1007/s12072-024-10659-5. Online ahead of print. Hepatol Int. 2024. PMID: 38451408 No abstract available.
Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver.
Ko M, Kamimura K, Owaki T, Nagoya T, Sakai N, Nagayama I, Niwa Y, Shibata O, Oda C, Morita S, Kimura A, Inoue R, Setsu T, Sakamaki A, Yokoo T, Terai S. Ko M, et al. Among authors: sakamaki a. Dis Model Mech. 2023 Dec 1;16(12):dmm050622. doi: 10.1242/dmm.050622. Epub 2023 Nov 30. Dis Model Mech. 2023. PMID: 38032301 Free PMC article. No abstract available.
Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis.
Kimura N, Takahashi K, Setsu T, Horibata Y, Kaneko Y, Miyazaki H, Ogawa K, Kawata Y, Sakai N, Watanabe Y, Abe H, Kamimura H, Sakamaki A, Yokoo T, Kamimura K, Tsuchiya A, Terai S. Kimura N, et al. Among authors: sakamaki a. Hepatol Res. 2024 Jan;54(1):67-77. doi: 10.1111/hepr.13966. Epub 2023 Sep 27. Hepatol Res. 2024. PMID: 37691006
Machine learning prediction model for treatment responders in patients with primary biliary cholangitis.
Kimura N, Takahashi K, Setsu T, Goto S, Miida S, Takeda N, Kojima Y, Arao Y, Hayashi K, Sakai N, Watanabe Y, Abe H, Kamimura H, Sakamaki A, Yokoo T, Kamimura K, Tsuchiya A, Terai S. Kimura N, et al. Among authors: sakamaki a. JGH Open. 2023 Jun 1;7(6):431-438. doi: 10.1002/jgh3.12915. eCollection 2023 Jun. JGH Open. 2023. PMID: 37359114 Free PMC article.
Cell-free and concentrated ascites reinfusion therapy versus large-volume paracentesis for the treatment of cirrhotic patients with refractory ascites: A multicenter prospective observational study.
Hanai T, Kawaratani H, Nagano J, Suii H, Sakamaki A, Arase Y, Nakanishi H, Kogiso T, Okubo T, Miwa T, Shimizu S, Hige S, Atsukawa M, Shimizu M, Kurosaki M, Terai S, Kagawa T, Tokushige K, Yoshiji H. Hanai T, et al. Among authors: sakamaki a. Hepatol Res. 2023 Mar;53(3):238-246. doi: 10.1111/hepr.13860. Epub 2022 Dec 3. Hepatol Res. 2023. PMID: 36433862
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression.
Sakai N, Kamimura K, Miyamoto H, Ko M, Nagoya T, Setsu T, Sakamaki A, Yokoo T, Kamimura H, Soki H, Tokunaga A, Inamine T, Nakashima M, Enomoto H, Kousaka K, Tachiki H, Ohyama K, Terai S. Sakai N, et al. Among authors: sakamaki a. J Gastroenterol. 2023 Jan;58(1):53-68. doi: 10.1007/s00535-022-01929-w. Epub 2022 Oct 27. J Gastroenterol. 2023. PMID: 36301364
61 results